FDA Inspection 977464 — Corden Pharma Colorado, Inc.

Corden Pharma Colorado, Inc. — FEI 1710165

The FDA completed an inspection of Corden Pharma Colorado, Inc. on February 12, 2016 in Boulder, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 12, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Boulder, CO (United States)